CKD-MBD includes three aspects: (1) laboratory abnormalities of calcium, phosphorus, parathormone (PTH), or vitamin D, (2) bone abnormalities in turnover, mineralization, volume, linear growth, or strength (osteodystrophy, osteopenia, osteoporosis, and low-mineral density), and (3) calcification of the vasculature or other soft tissues [1]. This evidence concerns the gene PTH and chronic kidney disease.